Press Releases

PathGroup Chooses Proscia To Deliver Next Generation Of Cancer Diagnosis For Millions of Patients

Providing faster, higher quality results with enterprise digital pathology

Microbialtec Releases Culture Medium to Support Microbial Research

Creative Biogene Offers Advanced Systems and High Quality CRISPR/Cas9 Kits for CRISPR/Cas9 Gene Editing

Histobiolab Provides Comprehensive Range of Fish Probes to Support Biotech Research

Creative Bioarray Launches GMP Grade Cytokines to Support Cell Manufacturing of Cell-based Therapies

Linus Health Announces Appointment of Leah Ray as Company’s First Chief Customer Officer

Linus Health, a digital health company focused on transforming brain health, today announced that Leah Ray has joined its executive leadership team as the company’s first Chief Customer Officer.

Cerba Research and Teddy Lab sign Memorandum of Understanding on entering into a discussion for Joint Venture

Cerba Research has announced a Memorandum of Understanding (MoU) with Teddy Clinical Research Laboratory to lay the foundation for an in-depth discussion towards the creation of a Joint Venture (JV).

SERDA therapeutics submits IND for its lead product, an innovative wound debridement agent

SERDA therapeutics has submitted an Investigational New Drug Application (IND) to the US FDA on the 17th February for its lead product SN514 hydrogel, an innovative enzymatic wound debriding agent. Clinical studies are expected to start in Q2 2023.

Photoactive Polymers, Alternative Energy Materials, and Micro-Nano Electric Materials

Alfa Chemistry Newly Releases Catalyst Analysis, Screening, Manufacturing, and Characterization Services

​Emory Healthcare Engages Linus Health on Initiative to Expand Early Detection of Alzheimer’s Disease and Other Dementias

Goizueta Institute @Emory Brain Health and The Seavey Clinic Collaborating on Use of Digital Cognitive Assessments in Primary Care

Spry Therapeutics Introduces the World's First “Clean and Green” Positioning Pillow for Healthcare

New partnership between Spry Therapeutics and Fiberpartner enables healthcare facilities to improve patient safety and sustainability while reducing costs.

Tasso High-Volume Liquid Blood Collection Device Earns CE Mark Certification

Tasso High-Volume Liquid Blood Collection Device Earns CE Mark Certification

Biopharma PEG Supplies Multi-arm PEG Derivatives Crosslinked Into Hydrogels

Amerigo Scientific Releases Optimal ZediXclusive TG6-ab ELISA (IgA) Kits to Detect TG6-Autoantibodies in Human Sera

Amerigo Scientific released ZediXclusive TG6-ab ELISA Kits (IgA), optimized based on ZediXplore TG6-ELISA Kits (IgA) to support celiac disease-related studies.

ScyTek announces a new special stain kit, The Martius Scarlet Blue (MSB) Stain Kit.

The Martius Scarlet Blue (MSB) stain kit is intended for use in the histological demonstration of fibrin, muscle, collagen, and erythrocytes. MSB is a reliable method of differentiating fresh and old fibrin clusters.

2/22 WEBINAR: Connected diagnostics: Do the benefits outweigh the costs?

Medical diagnostic innovations are rapidly changing the way health care services are delivered. From strengthening national and sub-national disease surveillance systems to equipping health care workers with quick and effective decision-making processes, connected diagnostics demonstrate multiple ways to transform and improve service delivery for individuals and communities. Despite the great potential and increased availability of these devices, decision-makers still lack clarity on their value proposition and are often unable to justify the investment required to scale up connected diagnostic systems. In this PATH Live Forum event, speakers will discuss the hurdles to investing in connected diagnostics and share insights from global and local health leaders on how to create an equitable, sustainable, and beneficial environment for connected diagnostics in global health.

BOC Sciences Live Webinar on Sensitive Nucleic Acids: Applications and Chemical Synthesis

Professor Shiyue Fang from the Department of Chemistry, Michigan Technological University, accepted BOC Sciences' invitation to present his insightful ideas about sensitive nucleic acid applications and chemical synthesis.

Verisense Health Introduces Eminent New Board of Advisors

Verisense® Health, Inc., a digital health software and data management company, today announced the four founding members of its Board of Advisors – Dr. William Crown, Paul Hartung, Dr. Ronald C. Kessler, and Josh Tolkoff. They bring large-scale medical research, statistical, epidemiological, operational and funding expertise to the company.

Kidney and Pancreas Function Diagnostic Enzymes Are Now Available at Creative Enzymes